Gradalis (United States)

Recent papers from Gradalis (United States)

1. In Vivo Assessment of dbDNA GNE wt /bi‐shRNA‐GNE M743T Lipoplex for GNE Myopathy: Improved Potency and SafetyThe Journal of Gene Medicine · 2026
2. Preclinical assessment of GNEwt/bi-shRNA-GNEM743T lipoplex product development for GNE myopathy.2026
3. Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden–High Ovarian CancerJCO Precision Oncology · 2026
4. Clinical characterization and therapeutic targeting of fusion genes in oncologyFuture Oncology · 2025
5. Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil productScientific Reports · 2025
6. Repair Assisted Damage Detection (RADD) as a predictive biomarker for immunotherapy response in ovarian cancerGynecologic Oncology · 2024
7. Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapyFuture Oncology · 2024
8. 3D engineered scaffold for large-scale Vigil immunotherapy productionScientific Reports · 2024
9. Regulatory role of CD39 and CD73 in tumor immunityFuture Oncology · 2024
10. Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian CancerInternational Journal of Molecular Sciences · 2024
11. Smart exosomes enhance PDAC targeted therapyJournal of Controlled Release · 2024
12. Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy ResponseCancers · 2023
13. Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian CancerOncology Reviews · 2023
14. Advances in Targeted Therapy for the Treatment of Cervical CancerJournal of Clinical Medicine · 2023
15. A Scalable Engineered Extracellular Matrix Platform to Expand Tumor CellsAdvanced NanoBiomed Research · 2023
16. Radial Scars Without Atypia Diagnosed at Percutaneous Core Needle Breast Biopsy: Support for Imaging SurveillanceEuropean Journal of Breast Health · 2022
17. Folate Receptor as a Biomarker and Therapeutic Target in Solid TumorsCurrent Problems in Cancer · 2022
18. Systemic benefit of radiation therapy via abscopal effectFrontiers in Oncology · 2022
19. NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian CancerOncology Reviews · 2022
20. ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancerCommunications Medicine · 2022